Results and prospects for the use of DPP-4 inhibitor in patients with diabetes mellitus type 2

Abstract

The incidence of diabetes worldwide is increasing annually, despite all efforts of the global healthcare. Cardiovascular complications remain the main cause of morbidity and mortality in patients with diabetes mellitus type 2.

Keywords

• сахарный диабет 2-го типа
• сахароснижающие препараты
• ситаглиптин
• diabetes mellitus type 2
• hypoglycemic agents
• sitagliptin